MARKET

ENLV

ENLV

Enlivex Therapeutics Ltd
NASDAQ
1.180
-0.030
-2.48%
After Hours: 1.180 0 0.00% 16:04 07/08 EDT
OPEN
1.200
PREV CLOSE
1.210
HIGH
1.200
LOW
1.140
VOLUME
62.81K
TURNOVER
--
52 WEEK HIGH
1.760
52 WEEK LOW
0.8101
MARKET CAP
28.14M
P/E (TTM)
-1.7985
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENLV last week (0630-0704)?
Weekly Report · 2d ago
Weekly Report: what happened at ENLV last week (0623-0627)?
Weekly Report · 06/30 11:50
Weekly Report: what happened at ENLV last week (0616-0620)?
Weekly Report · 06/23 11:40
Weekly Report: what happened at ENLV last week (0609-0613)?
Weekly Report · 06/16 11:49
Enlivex Therapeutics to present clinical data of Allocetra in osteoarthritis
TipRanks · 06/10 12:40
Enlivex Therapeutics To Feature Data From Ongoing Clinical Study Evaluating Proprietary Allocetra Off-The-Shelf Macrophage Reprogramming Cell Therapy, In Patients With Knee Osteoarthritis At EULAR European Congress Of Rheumatology
Benzinga · 06/10 12:34
Weekly Report: what happened at ENLV last week (0602-0606)?
Weekly Report · 06/09 11:51
Weekly Report: what happened at ENLV last week (0526-0530)?
Weekly Report · 06/02 12:01
More
About ENLV
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Webull offers Enlivex Therapeutics Ltd stock information, including NASDAQ: ENLV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENLV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENLV stock methods without spending real money on the virtual paper trading platform.